Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Application of the Modified Story Memory Technique (mSMT)© to Aging
Authors not listed
Kessler Foundation · 2017
Abstract
This study is a double-blind placebo-controlled randomized clinical trial (RCT) to provide Class I evidence in support of or in refute of the efficacy of the modified Story Memory Technique (mSMT) in healthy aging (HA)and in persons with mild cognitive impairment (MCI). Outcomes will be measured through three mechanisms: (1) a traditional neuropsychological evaluation (NPE) (2) an assessment of global functioning (AGF) examining the impact of the treatment on daily activities, and (3) an optional functional magnetic resonance imaging (fMRI) scan.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Anonymous. (2017). Application of the Modified Story Memory Technique (mSMT)© to Aging. <em>Kessler Foundation</em>. https://clinicaltrials.gov/study/NCT03370224
Vancouver
Anonymous. Application of the Modified Story Memory Technique (mSMT)© to Aging. Kessler Foundation. 2017.
BibTeX
@misc{anon2017Applic,
title = {Application of the Modified Story Memory Technique (mSMT)© to Aging},
author = {Anonymous},
journal = {Kessler Foundation},
year = {2017},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Kessler Foundation 2023
Open access · US-GOV
Use of a Memory Technique to Improve New Learning and Memory in Individuals With Mild Cognitive Impairment
Behavioural Brain Research 2013
Citation only
Brain aging, memory impairment and oxidative stress: A study in Drosophila melanogaster
Immunotec Inc. 2018
Open access · US-GOV
Nutritional Intervention With the Cysteine-rich Whey Protein Isolate Dietary Supplement Immunocal® in MCI Patients: Promotion of Brain Health & Wellness During Aging and Oxidative Stress
Frontiers in endocrinology
Open access · OA
Editorial: Neuroendocrine aging: inflammation, oxidative stress, and cognitive impairment
Green Valley (Shanghai) Pharmaceuticals Co., Ltd. 2020
Open access · US-GOV
A Phase 3, Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Sodium Oligomannate (GV-971) in Treatment of Mild to Moderate Alzheimer's Disease (GREEN MEMORY: GREen Valley 971 EvaluatioN Memory)
Duke University 2024
Open access · US-GOV